In the News

486 News Items found
A researcher working in an MSK lab
MSK Research Highlights, February 13, 2025
New MSK research supported the approval of a new treatment for ER-positive, HER2-negative advanced breast cancer; suggests a new strategy for overcoming resistance to Akt inhibitors in patients with PTEN-mutated prostate cancers; provides new understanding of B cell lymphomas that could lead to new treatments; examines using ChatGPT to help capture patient-reported outcomes; and developed the first customizable, scalable model for palliative care training for emergency departments.
A sign welcomes attendees to the AACR meeting in New Orleans.
Roundup
MSK studies presented at the 2022 American Association for Cancer Research meeting include updates on a targeted therapy for lung cancer, lab research on combining statins with a breast cancer drug, and a new tool for diagnosing blood cancer.
MSK patient Ellen Coopersmith smiling in a rowboat in Central Park
Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers.
MSK computational biologist Dana Pe'er
In the Lab
Sloan Kettering Institute investigators are taking important steps toward being able to identify all the cell types in tumors. With this information, they can figure out how the cells work together.
memorial sloan kettering patient katie gay
Find out why you still need your routine mammogram, even during COVID-19.
Amy Speck
Learn about some of the most important advances in cancer treatment and clinical trials at MSK in 2024.
MSK offers a number of support services for women going through menopause during or after breast cancer treatment.
Support
Learn how to manage menopause symptoms if you have breast cancer
Sohrab Shah
A multi-institution team co-led by MSK researchers has pinpointed what could be the early genetic origins of breast cancer.
Woman smiling with Central Park in the background.
Article
Learn about a three-drug treatment that has been shown to extend survival for ER+, HER2- breast cancers.
MSK breast cancer patient Majiel Baker is seen at the beach with her husband and children.
Learn why over 5,000 people a year travel more than 150 miles to MSK for cancer care, including resources for the specific needs of traveling patients and their loved ones.